Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Harvey

Neurological Surgery Independence, MO Medical Doctor

NPI 1235235938 CMS profile 11180

19550 E 39Th St S Ste 227, Independence, MO 64057

Open in the dashboard

General payments

$20,446

216 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Harvey of Independence, MO is reported in the CMS Open Payments database as having received $20,446 across 216 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $527 12
2024 General $1,515 15
2023 General $1,643 24
2022 General $1,180 20
2021 General $3,373 34
2020 General $6,072 38
2019 General $6,135 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Harvey
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Charles Harvey were reported at $527. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Charles Harvey Neurological Surgery median Middle half National median
2019 $6,135 $582 $138–$3,006 $163
2020 $6,072 $294 $76–$2,174 $114
2021 $3,373 $387 $105–$2,432 $132
2022 $1,180 $542 $139–$2,989 $149
2023 $1,643 $534 $145–$2,697 $160
2024 $1,515 $574 $155–$3,046 $164
2025 $527 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $7,274 64 payments
  2. Alphatec Spine, Inc $2,466 15 payments
  3. SI-BONE, Inc. $2,120 22 payments
  4. Synaptive Medical Inc. $1,885 11 payments
  5. Medtronic, Inc. $1,859 18 payments
  6. RTI Surgical, Inc. $978 6 payments
  7. Abbott Laboratories $898 12 payments
  8. Medtronic USA, Inc. $871 18 payments
  9. Stryker Corporation $726 14 payments
  10. NuVasive, Inc. $227 5 payments
  11. Other $1,144 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,215 186 payments
  2. Travel and Lodging $9,731 29 payments
  3. Consulting Fee $500 1 payment
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $2,106 9 payments
  2. ELSA $1,791 9 payments
  3. Excelsius - GPS $1,725 8 payments
  4. Excelsius Robotics System $1,714 4 payments
  5. Brightmatter Guide V $1,505 7 payments
  6. Mazor X Stealth Edition $1,188 8 payments
  7. IFUSE IMPLANT SYSTEM $865 1 payment
  8. IFUSE IMPLANT $657 10 payments
  9. SlMMETRY $532 2 payments
  10. EXCELSIUS GPS $528 5 payments
  11. Other $8,285 167 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

82

Median for Neurosurgery: 83

Drug cost

$1,226

Median for Neurosurgery: $872

Branded share of claims

65.9%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $610
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 18 $289
Pregabalin Generic 12 $180
Cyclobenzaprine Hcl Generic 16 $146

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$70,886

Medicare's payments for the services billed

Medicare patients

161

Average age 75

Services billed

408

94 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Depression 49%
Ischemic heart disease 40%
Chronic kidney disease 37%
Diabetes 34%
Atrial fibrillation 33%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

216 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record